Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237500, C514S262100, C514S266100, C514S354000, C514S406000, C514S423000, C514S741000, C544S168000, C544S256000, C544S283000, C544S334000, C546S314000, C548S374100, C548S537000, C548S953000, C549S487000, C564S152000
Reexamination Certificate
active
07378409
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
REFERENCES:
patent: 3226419 (1965-12-01), Zangg et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6362177 (2002-03-01), Shiota et al.
patent: 6410566 (2002-06-01), Shiota et al.
patent: 6451842 (2002-09-01), Shiota et al.
patent: 6624184 (2003-09-01), Gu et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2003/0060459 (2003-03-01), Carter et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2003/0229119 (2003-12-01), Kym et al.
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: 2373186 (2002-09-01), None
patent: 2003183286 (2003-07-01), None
patent: WO 9633170 (1996-10-01), None
patent: WO 9805336 (1998-02-01), None
patent: WO 9845262 (1998-10-01), None
patent: WO 9925686 (1999-05-01), None
patent: WO 9926615 (1999-06-01), None
patent: WO 99/52895 (1999-10-01), None
patent: WO 0000464 (2000-01-01), None
patent: WO 00/26197 (2000-05-01), None
patent: WO 0069432 (2000-11-01), None
patent: WO 0069815 (2000-11-01), None
patent: WO 0076970 (2000-12-01), None
patent: WO 0076971 (2000-12-01), None
patent: WO 0077027 (2000-12-01), None
patent: WO 0110439 (2001-02-01), None
patent: WO 0114333 (2001-03-01), None
patent: WO 0142208 (2001-06-01), None
patent: WO 0144226 (2001-06-01), None
patent: WO 0147875 (2001-07-01), None
patent: WO 0192204 (2001-12-01), None
patent: WO 0250019 (2002-06-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 02/089783 (2002-11-01), None
patent: WO 03000657 (2003-01-01), None
patent: WO 03000680 (2003-01-01), None
patent: WO 03016302 (2003-02-01), None
patent: WO 03/022799 (2003-03-01), None
patent: WO 03028641 (2003-04-01), None
patent: WO 03068233 (2003-08-01), None
patent: WO 03068235 (2003-08-01), None
patent: WO 03070244 (2003-08-01), None
patent: WO 03070244 (2003-08-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004/050024 (2004-06-01), None
patent: WO 2004/058715 (2004-07-01), None
patent: WO 2004/071449 (2004-08-01), None
patent: WO 2004/087669 (2004-10-01), None
patent: WO 2004/098512 (2004-11-01), None
patent: WO 2004/098516 (2004-11-01), None
patent: WO 2004/098516 (2004-11-01), None
Ritter et al., “Amino Acid-Derived Chiral Acyl Nitroso Compounds: Diastereoselectivity in Intermolecular Hetero Diels-Alder Reactions”, Journal of Organic Chemistry, vol. 59 (16), pp. 4602-4611, 1994.
Berkhout et al., “CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach”, Journal of Medicinal Chemistry, vol. 46(19), pp. 4070-4086, 2003.
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/922,726, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/776,828, filed Feb. 11, 2004, Cherney et al.
Grabowski, et al., Tetrahedron Letters, Elsevier, Amsterdam, NL, vol. 38, No. 31, pp. 5485-5488 (1997).
Tanaka et al., European Journal of Organic Chemistry, vol. 16, pp. 3043-3046 (Aug. 2003).
Batt Douglas G.
Brown Gregory D.
Carter Percy H.
Cherney Robert J.
Duncia John V.
Bogie Terence J.
Bristol--Myers Squibb Company
Duncan Laurelee L.
Kosack Joseph R.
Saeed Kamal A.
LandOfFree
Substituted cycloalkylamine derivatives as modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cycloalkylamine derivatives as modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cycloalkylamine derivatives as modulators of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2808506